---
url: 'https://wagner.nyu.edu/community/faculty/alexander-niyazov'
title: 'Alexander Niyazov'
author:
  name: an4027
  url: 'https://wagner.nyu.edu/user/73776'
date: '2022-09-15T20:33:23+00:00'
updated: '2026-04-01T18:48:31+00:00'
type: faculty
summary: "Dr. Niyazov is currently the Senior Director, Global Value and Evidence, Pipeline Oncology Team Lead at Pfizer Oncology. In this role, he oversees a team of outcomes researchers who generate evidence to demonstrate the value proposition of early-stage oncology assets.\_\_Prior to joining Pfizer, Dr. Niyazov held roles of increasing responsibilities across various pharmaceutical companies including Bayer, Novartis, and Acorda Therapeutics where he supported oncology and CNS assets.\_Before transitioning to the pharmaceutical industry, Dr. Niyazov worked across several health systems as an oncology pharmacist, pharmacy supervisor, and as an assistant director of pharmacy operations. In those roles, he was involved in population health management and formulary decision making. Dr. Niyazov obtained his PharmD degree from Long Island University, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, his Master’s in Public Health from Columbia University, Mailman School of Public Health, and his Juris Doctor from St. John's University School of Law.\_\_Dr. Niyazov has held faculty appointments at several universities where he taught courses such as delivery of healthcare in the US, international health technology assessment, subjective outcomes in health evaluation, outcomes and economic analysis, cultural competence, health policy and management, clinical trial and research management, intellectual property, compliance and regulation, and advanced pharmacology.\_\_Dr. Niyazov has published extensively in the field of real-world evidence, economic modeling, patient reported outcomes, and the impact of health disparities on access to healthcare.\_\_Dr. Niyazov currently resides in Queens, NY with his wife Olga, and their children. In his spare time, Dr. Niyazov enjoys traveling and spending time with his family."
tags:
  - 'MPA in Health Policy & Management'
  - Adjunct
  - Management
image: 'https://wagner.nyu.edu/files/faculty/headshots/aleksandr-niyazov-3.jpg'
published: true
schema:
  '@context': 'https://schema.org'
  '@graph':
    -
      '@type': Person
      name: 'Alexander Niyazov'
      familyName: Niyazov
      givenName: Alexander
      description: "Dr. Niyazov is currently the Senior Director, Global Value and Evidence, Pipeline Oncology Team Lead at Pfizer Oncology. In this role, he oversees a team of outcomes researchers who generate evidence to demonstrate the value proposition of early-stage oncology assets.\_\_Prior to joining Pfizer, Dr. Niyazov held roles of increasing responsibilities across various pharmaceutical companies including Bayer, Novartis, and Acorda Therapeutics where he supported oncology and CNS assets.\_Before transitioning to the pharmaceutical industry, Dr. Niyazov worked across several health systems as an oncology pharmacist, pharmacy supervisor, and as an assistant director of pharmacy operations. In those roles, he was involved in population health management and formulary decision making. Dr. Niyazov obtained his PharmD degree from Long Island University, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, his Master’s in Public Health from Columbia University, Mailman School of Public Health, and his Juris Doctor from St. John's University School of Law.\_\_Dr. Niyazov has held faculty appointments at several universities where he taught courses such as delivery of healthcare in the US, international health technology assessment, subjective outcomes in health evaluation, outcomes and economic analysis, cultural competence, health policy and management, clinical trial and research management, intellectual property, compliance and regulation, and advanced pharmacology.\_\_Dr. Niyazov has published extensively in the field of real-world evidence, economic modeling, patient reported outcomes, and the impact of health disparities on access to healthcare.\_\_Dr. Niyazov currently resides in Queens, NY with his wife Olga, and their children. In his spare time, Dr. Niyazov enjoys traveling and spending time with his family."
---
# Alexander Niyazov

## Adjuct Assistant Professor of Health Policy &amp; Management

 

 Contact Details<an4027@nyu.edu>

 

 

 

 

 

 

 

- <a aria-controls="tabpanel-faculty-body" aria-selected="true" id="tab-faculty-body" role="tab" tabindex="0"> Bio </a>
- <a aria-controls="tabpanel-faculty-field_faculty_syllabus" aria-selected="false" id="tab-faculty-field_faculty_syllabus" role="tab" tabindex="-1"> Courses </a>
 
 

 <a aria-label="Bio - Click to expand or collapse" tabindex="-1"> Bio     </a> 

Dr. Niyazov is currently the Senior Director, Global Value and Evidence, Pipeline Oncology Team Lead at Pfizer Oncology. In this role, he oversees a team of outcomes researchers who generate evidence to demonstrate the value proposition of early-stage oncology assets.  Prior to joining Pfizer, Dr. Niyazov held roles of increasing responsibilities across various pharmaceutical companies including Bayer, Novartis, and Acorda Therapeutics where he supported oncology and CNS assets. Before transitioning to the pharmaceutical industry, Dr. Niyazov worked across several health systems as an oncology pharmacist, pharmacy supervisor, and as an assistant director of pharmacy operations. In those roles, he was involved in population health management and formulary decision making. Dr. Niyazov obtained his PharmD degree from Long Island University, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, his Master’s in Public Health from Columbia University, Mailman School of Public Health, and his Juris Doctor from St. John's University School of Law.  Dr. Niyazov has held faculty appointments at several universities where he taught courses such as delivery of healthcare in the US, international health technology assessment, subjective outcomes in health evaluation, outcomes and economic analysis, cultural competence, health policy and management, clinical trial and research management, intellectual property, compliance and regulation, and advanced pharmacology.  Dr. Niyazov has published extensively in the field of real-world evidence, economic modeling, patient reported outcomes, and the impact of health disparities on access to healthcare.  Dr. Niyazov currently resides in Queens, NY with his wife Olga, and their children. In his spare time, Dr. Niyazov enjoys traveling and spending time with his family.

 

 

 <a aria-label="Courses - Click to expand or collapse" tabindex="-1"> Courses     </a> 

  [## Spring 2026

###  HPAM-GP.4830.: Health Economics: Principles 

 ](#showMore--430836) 

This course provides the core microeconomic theories and concepts needed to understand health and health care issues in both the developed and developing world. It describes how the markets for health and health services are different from other goods, with a particular emphasis on the role of government and market failure. In addition it discusses the theoretical and empirical aspects of key health economics issues, including the demand for health and health services, supply side concerns, health insurance, the provision of public goods, and related topics. The course encourages students to fundamentally and rigorously examine the role of the market for the provision of health and health services and how public policy can influence these markets.

 

 [Download Syllabus (login required)](https://wagner.nyu.edu/saml/login?destination=/system/files/syllabi/202601/HPAM-GP-4830.001.docx) 



  [## Spring 2026

###  HPAM-GP.4831.: Health Economics: Topics in Domestic Health Policy 

 ](#showMore--430841) 

Building on HPAM-GP.4830, this course examines US domestic health policy issues from an economics perspective. Topics covered will be influenced by the current policy topics under discussion in the US. We will focus on the tradeoffs and contrasts between a market-based versus a government-based system, with topics potentially including: choice and behavioral economics, payment policies/pay-for-performance, health insurance, relevant sectors of the US health care system (hospitals, etc), public health and innovation. There will be a strong focus on applying theoretical insights from HPAM-GP 4830 and interpreting the relevant empirical literature.

 

 [Download Syllabus (login required)](https://wagner.nyu.edu/saml/login?destination=/system/files/syllabi/202601/syllabus-spring-2026-4831-final.docx)